Efficacy and safety of motesanib, an oral inhibitor of VEGF, PDGF, and Kit receptors, in patients with imatinib-resistant gastrointestinal stromal tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/20838998

Download in:

View as

General Info

PMID
20838998